Clq nephropathy presenting as rapidly progressive crescentic glomerulonephritis

被引:26
作者
Srivastava, T
Chadha, V
Taboada, EM
Alon, US
机构
[1] Univ Missouri, Childrens Mercy Hosp, Nephrol Sect, Kansas City, MO 64108 USA
[2] Univ Missouri, Childrens Mercy Hosp, Dept Pathol, Kansas City, MO 64108 USA
关键词
Clq nephropathy; crescentic glomerulonephritis; renal failure; immune complex glomerulonephritis;
D O I
10.1007/s004670050056
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
C1q nephropathy is an immune complex glomerulonephritis defined by the presence of mesangial immunoglobulins and complement deposits, most notably C1q, and the absence of clinical and laboratory evidence of systemic lupus erythematosus. Histology in C1q nephropathy is characterized by a slight to severe increase in mesangial cellularity and matrix, with or without segmental sclerosis. C1q nephropathy usually presents with nephrotic-range proteinuria in older children and young adults, and has a poor response to steroids. Patients may have decreased creatinine clearance at presentation, but progression to end-stage renal disease (ESRD) is slow. Seven crescentic glomerulonephritis has not been reported in C1q nephropathy. We describe a 3-year-old Hispanic girl who presented with renal insufficiency. Kidney biopsy showed C1q nephropathy with severe crescentic glomerulonephritis. The clinical and serological evaluation ruled out systemic lupus erythematosus or other immunological or infectious etiologies. In spite of immunosuppressive therapy, she progressed to ESRD within 14 weeks and is currently on chronic peritoneal dialysis. The atypical features of C1q nephropathy observed in our patient, which have not been described in earlier reports, are an early age of onset, severe crescentic glomerulonephritis, and rapid progression to ESRD. C1q nephropathy should be added to the differential diagnosis of glomerulonephritis in young children and in the patient with crescentic glomerulonephritis.
引用
收藏
页码:976 / 979
页数:4
相关论文
共 12 条
[1]  
ANDREWS BS, 1981, J IMMUNOL, V127, P1075
[2]   C1Q NEPHROPATHY - A PEDIATRIC CLINICOPATHOLOGICAL STUDY [J].
ISKANDAR, SS ;
BROWNING, MC ;
LORENTZ, WB .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (04) :459-465
[3]  
Jennette J. Charles, 1993, Journal of the American Society of Nephrology, V4, P681
[4]   C1Q NEPHROPATHY - A DISTINCT PATHOLOGIC ENTITY USUALLY CAUSING NEPHROTIC SYNDROME [J].
JENNETTE, JC ;
HIPP, CG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 6 (02) :103-110
[5]   IMMUNOHISTOPATHOLOGIC EVALUATION OF C1Q IN 800 RENAL BIOPSY SPECIMENS [J].
JENNETTE, JC ;
HIPP, CG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 83 (04) :415-420
[6]  
JONES E, 1982, AM J CLIN PATHOL, V78, P29, DOI 10.1093/ajcp/78.1.29
[7]  
LOOS M, 1982, PROG ALLERGY, V30, P135
[8]   An adolescent with relapsing nephrotic syndrome: Minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy [J].
Shappell, SB ;
Myrthil, G ;
Fogo, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (06) :966-970
[9]   C1Q BINDING TO HUMAN VASCULAR SMOOTH-MUSCLE CELLS MEDIATES IMMUNE-COMPLEX DEPOSITION AND SUPEROXIDE GENERATION [J].
SHINGU, M ;
YOSHIOKA, K ;
NOBUNAGA, M ;
MOTOMATU, T .
INFLAMMATION, 1989, 13 (05) :561-569
[10]  
SILVA FG, 1988, MODERN PATHOL, V1, P292